Ocular Therapeutix Inc. (NASDAQ:OCUL) is a biopharmaceutical company that develops and commercializes therapies for retinal ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

Exercise improves quality of life and sleep in ovarian cancer patients, with moderate and significant benefits, respectively. Methodological variability and high heterogeneity in trials highlight the ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Data included more than a million participants to find that Alzheimer's risk was up to 76% lower in these cases.

Clinical trials continue to shape metastatic breast cancer treatment, making therapies safer, more tolerable, and more ...

New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional ...

Plants form a critical model for understanding regulated cell death (RCD) as part of their sophisticated immune responses. In the ongoing evolutionary arms ...

A simple mechanism to protect your teams’ roadmap, deliverables and productivity when the next fire drill hits.

Proteins circulating in the blood can reveal what's happening in the body, from how we process energy to how diseases develop ...

Short-term mortality outcomes in shock were noninferior among critically ill patients managed without vs with early arterial catheter insertion.